Showing results (91-100 of 182) with videos related to
Sort By:
Pageof 19
Prostate International|August 20, 2015
E74-like factor inhibition induces reacquisition of hormone sensitiveness decreasing period circadian protein homolog 1 expression in prostate cancer cellsKohei Koyama, Kiyoshi Takahara, Teruo Inamoto, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 1, 2016
[A CASE OF ADVANCED BLADDER NEUROENDOCRINE CARCINOMA (SMALL CELL CARCINOMA) SIGNIFICANTLY IMPROVED BY LOW DOSE OF ORAL TEGAFUR-URACIL]Hayahito Nomi, Kiyoshi Takahara, Koichiro Minami, et al.International Journal of Oncology|November 27, 2010
Utility of the novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen), for elderly patients with invasive bladder cancerHaruhito Azuma, Teruo Inamoto, Naokazu Ibuki, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2019
Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS Networks of Renal Cell Cancer Cells In Vitro and In VivoTomoaki Takai, Takuya Tsujino, Yuki Yoshikawa, et al.Current Urology|January 25, 2021
Tumor Location Based Segmentation in Upper-Tract Urothelial Carcinoma Impacts on the Urothelial Recurrence-Free Survival: A Multi-Institutional Database StudyTeruo Inamoto, Hideyasu Matsuyama, Kazumasa Komura, et al.Oncotarget|January 20, 2018
The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinomaTeruo Inamoto, Hideyasu Matsuyama, Shigeru Sakano, et al.Cancer Research|December 18, 2003
Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanismHaruhito Azuma, Teruo Inamoto, Takeshi Sakamoto, et al.The Journal of Urology|October 18, 2017
Biological Behavior and Long-Term Outcomes of Carcinoma In Situ in Upper Urinary Tract Managed by Radical NephroureterectomyTeruo Inamoto, Hideyasu Matsuyama, Naokazu Ibuki, et al.Journal of Medical Case Reports|April 11, 2017
Remarkable response to fluorouracil, leucovorin, oxaliplatin, and irinotecan therapy in urothelial cancer of the renal pelvis: a case reportTakuya Tsujino, Kiyoshi Takahara, Tomohisa Matsunaga, et al.Transplantation|November 19, 2010
Induction of donor-specific tolerance using superagonistic CD28 antibody in rat renal allografts: regulatory T-cell expansion before engraftment may be importantHaruhito Azuma, Yoshitaka Isaka, Hayahito Nomi, et al.Pageof 19